The underlying mechanism appears to involve RFC4, which promotes cancer cell proliferation, while reducing the RFC4 levels induces the formation of an enriched population of CRC cells in the S phase and a decrease in CRC cells proliferation. The gene discussed is RFC4; the disease is colorectal carcinoma.